The Children’s Research Institute Seminar Series: “Epigenetic Modulation of the Cancer Antigen GD2 to Improve Immunotherapy in Pediatric Solid Tumors”
Justin Sperlazza is a pediatric oncologist working on understanding how chromatin-directed therapeutics can influence tumor susceptibility to immunotherapy, particularly CAR-T therapy, in Ewing’s Sarcoma. Please contact childrensresearch@med.unc.edu for Zoom details. In person, 3116 Mary Ellen Jones & Zoom option. Children's Research Institute 919-962-3424 https://www.med.unc.edu/childrensresearch/ childrensresearch@med.unc.edu